首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1781301

全球髂動脈支架市場

Iliac Stents

出版日期: 2025年08月01日 | 出版商:

Global Industry Analysts, Inc. | 英文 377 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球髂動脈支架市場規模將達 11 億美元

全球髂動脈支架市場規模預計在2024年達到9.167億美元，預計在2024-2030年的分析期間內將以3.4%的複合年成長率成長，到2030年將達到11億美元。自動擴張型支架支架是本報告分析的細分市場之一，預計其複合年成長率為2.6%，到分析期結束時規模將達到5.806億美元。球囊擴張型支架在分析期間的複合年成長率預計為4.5%。

美國市場規模估計為 2.497 億美元，中國市場預計複合年成長率為 6.2%

預計到2024年，美國髂動脈支架市場規模將達到2.497億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到2.208億美元，2024年至2030年的複合年成長率為6.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為1.4%和2.6%。在歐洲，預計德國市場的複合年成長率為1.9%。

髂動脈支架：為何其對於治療周邊動脈疾病和複雜血管疾病至關重要

全球髂動脈支架市場－主要趨勢與促進因素摘要

全球髂動脈支架市場正在經歷顯著成長，這得益於周邊動脈疾病(PAD) 盛行率的上升、對微創血管介入治療的需求不斷成長以及支架技術的持續進步。髂動脈支架用於治療髂動脈的阻塞或狹窄（狹窄），髂動脈為骨盆和下肢供血。這種疾病通常由動脈粥狀硬化引起，如果不及時治療，會導致嚴重的肢體缺血。老年患者以及患有糖尿病、高血壓和高血脂症等併發症的患者對髂動脈支架的需求尤其強烈，因為他們更容易出現血管併發症。

近年來，開放性手術轉向血管內治療 (EVT)，髂動脈置入術因其發病率較低、住院時間較短、恢復速度較快而成為黃金標準。血管診斷可及性的提高、醫療保險覆蓋範圍的擴大以及全球周邊動脈疾病 (PAD)篩檢計畫的增加也推動了市場的成長。同時，臨床醫生對髂動脈疾病早期發現和積極治療的認知不斷提高，尤其是在高風險族群中。這些動態正為已開發市場及新興市場帶來強勁的支架置入術及相關器材需求。

哪些創新正在改善髂骨支架的設計和結果？

支架設計和輸送系統的技術進步是市場擴張的主要驅動力。製造商不斷創新，以提高支架的靈活性、徑向強度和長期通暢性，特別是在髂骨分叉等複雜的解剖區域。自動擴張型支架通常由鎳鈦諾（一種鎳鈦合金）製成，由於其順應性和抗外部壓縮性，在彎曲或移動的動脈中是首選。另一方面，球囊擴張型支架允許精確放置並提供更大的徑向力，使其適用於高度鈣化或局部病變。結合了兩種支架優點的混合支架也越來越受歡迎。

藥物釋放型支架 (DES) 已成為一項突破性技術，可釋放紫杉醇和Sirolimus等抗增殖藥物，從而降低血管再阻塞率。雖然 DES 通常用於冠狀動脈，但良好的臨床結果已使其廣泛應用於包括髂動脈在內的周邊動脈。此外，正在開發生物可吸收支架和無聚合物塗層，以盡量減少長期併發症，例如晚期支架血栓症形成。輸送系統的改進，包括細導管和親水塗層，有助於在複雜病灶中導航並縮短手術時間。這些技術進步使髂動脈置入術更安全、更有效率、更耐用，同時擴大了病患群體。

髂骨支架的需求在哪裡增加？

北美和西歐憑藉其先進的醫療基礎設施、較高的周邊動脈疾病 (PAD) 盛行率以及早期採用新型血管技術，繼續在髂動脈支架市場佔據主導地位。尤其是美國，其憑藉其完善的臨床指南支持血管內治療，且周邊動脈疾病 (PAD) 治療的報銷範圍廣泛，成為領先的市場。德國、法國和英國等歐洲國家也因其人口老化和積極的血管篩檢措施而顯示出強勁的需求。

亞太地區已成為一個高成長市場，其中以中國、印度和日本為主導。公共衛生意識的增強、介入性心臟病學和放射學服務可及性的提高以及心血管危險因素負擔的增加等因素推動了手術量的增加。此外，這些地區的政府正在投資發展三級醫療機構和農村推廣計劃，以提高周邊動脈疾病（PAD）的診斷和干涉的可及性。受醫療旅遊、保險滲透率和醫療保健基礎設施改善的推動，拉丁美洲以及中東和非洲部分地區也在逐步採用周邊動脈疾病 (PAD)。在所有地區，醫生培訓的加強以及醫療設備製造商和醫院之間的策略合作夥伴關係的建立正在加速髂動脈留置技術的推廣。

髂動脈支架市場的成長受到多種因素的推動…

髂動脈支架市場的成長受到多種因素的驅動，這些因素與疾病流行程度、技術進步以及終端應用的不斷擴展有關。其中一個關鍵促進因素是全球周邊動脈疾病發病率的上升，而人口老化以及吸菸、超音波和久坐不動等生活方式相關的風險因素是導致這一現象的根源。隨著周邊動脈疾病 (PAD) 的日益普遍，對髂動脈支架等有效重組手術的需求持續成長。此外，雙層超音波、CT血管攝影和磁振造影血管攝影等診斷影像技術的進步，有助於早期準確地識別髂動脈狹窄。

技術創新仍然是市場擴張的關鍵。新型支架平台的開發，使其能夠提高輸送能力、減少血管再阻塞並延長耐用性，從而吸引醫生的偏好並改善臨床療效。隨著低調、微創支架系統的興起，終端應用也正在從傳統的血管中心擴展到門診和門診手術中心。此外，有利的監管核准、不斷增加的臨床試驗證據以及支付方對血管內治療的支持力度不斷加大，正在推動支架系統更廣泛的應用。

最後，全球醫療保健趨勢，例如轉向基於價值的醫療模式、患者意識的提升以及人工智慧與血管診斷的融合，正在重塑髂動脈疾病的治療方式。這些趨勢強化了髂動脈支架作為周邊動脈疾病（PAD）第一線治療手段的策略重要性，並確保了不同地區、醫療機構和患者群體對髂動脈支架的需求持續成長。

部分

類型（自動擴張型支架型、球囊擴張型支架型、覆膜支架型）；動脈病變（髂總動脈病變、重度鈣化性動脈病變、完全閉塞性動脈病變）；最終用戶（醫院最終用戶、門診手術中心最終用戶、其他最終用戶）

受訪公司範例

Abbott Laboratories
Alvimedica
B. Braun Melsungen AG
Becton, Dickinson and Company（BD）
Biotronik SE & Co. KG
Boston Scientific Corporation
CR Bard, Inc.
Cardinal Health, Inc.
Cook Medical LLC
Cordis Corporation
Endologix LLC
Getinge AB
iVascular
Jotec GmbH
LeMaitre Vascular, Inc.
Medtronic plc
MicroPort Scientific Corporation
OptiMed Medizinische Instrumente GmbH
Terumo Corporation
WL Gore & Associates, Inc.

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

The global market for Iliac Stents estimated at US$916.7 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Self-Expandable Stents Type, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$580.6 Million by the end of the analysis period. Growth in the Balloon-Expandable Stents Type segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$249.7 Million While China is Forecast to Grow at 6.2% CAGR

The Iliac Stents market in the U.S. is estimated at US$249.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$220.8 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Iliac Stents: Why Are They Pivotal in Managing Peripheral Artery Disease and Complex Vascular Conditions?

Global Iliac Stents Market - Key Trends & Drivers Summarized

The global iliac stents market is experiencing significant growth, fueled by the rising prevalence of peripheral artery disease (PAD), increased demand for minimally invasive vascular interventions, and ongoing advancements in stent technology. Iliac stents are deployed to treat occlusions or narrowing (stenosis) in the iliac arteries, which supply blood to the pelvis and lower limbs. This condition often stems from atherosclerosis and can lead to critical limb ischemia if left untreated. The demand for iliac stents is particularly strong in elderly populations and patients with comorbidities such as diabetes, hypertension, and hyperlipidemia-conditions that predispose individuals to vascular complications.

Recent years have seen a shift from open surgical repair to endovascular treatment (EVT), with iliac stenting becoming the gold standard due to its lower morbidity, shorter hospital stays, and quicker recovery. Market growth is also being supported by increasing access to vascular diagnostics, expanded health insurance coverage, and a rising number of PAD screening programs globally. In parallel, there is growing awareness among clinicians regarding early detection and aggressive treatment of iliac artery disease, especially in high-risk populations. These dynamics are contributing to a strong demand pipeline for stenting procedures and related devices in both developed and emerging healthcare markets.

What Technological Innovations Are Enhancing Iliac Stent Design and Outcomes?

Technological advancement in stent design and delivery systems is a key driver of market expansion. Manufacturers are continuously innovating to improve stent flexibility, radial strength, and long-term patency-especially in complex anatomical regions like the iliac bifurcation. Self-expanding stents, typically made of nitinol (a nickel-titanium alloy), are favored in tortuous or mobile arteries due to their conformability and resistance to external compression. Balloon-expandable stents, on the other hand, offer precision placement and higher radial force, making them suitable for heavily calcified or focal lesions. Hybrid stents that combine the benefits of both designs are also gaining traction.

Drug-eluting stents (DES) have emerged as a game-changer, releasing antiproliferative agents such as paclitaxel or sirolimus to reduce restenosis rates. While DES are more commonly used in coronary arteries, their application in peripheral settings-including the iliac arteries-is expanding due to favorable clinical outcomes. In addition, bioresorbable scaffolds and polymer-free coatings are under development to minimize long-term complications such as late stent thrombosis. Improved delivery systems, including low-profile catheters and hydrophilic coatings, are making it easier to navigate complex lesions and reduce procedure time. These innovations are making iliac stenting safer, more efficient, and more durable, while expanding eligibility to broader patient populations.

Where Is Market Demand for Iliac Stents Growing - And What’s Driving It?

North America and Western Europe continue to dominate the iliac stents market, owing to advanced healthcare infrastructure, high prevalence of PAD, and early adoption of novel vascular technologies. The U.S., in particular, is a key market due to robust clinical guidelines supporting endovascular interventions and extensive reimbursement coverage for PAD treatment. European countries such as Germany, France, and the UK also exhibit strong demand, driven by aging populations and proactive vascular screening initiatives.

The Asia-Pacific region is emerging as a high-growth market, with China, India, and Japan leading the charge. Factors such as growing public health awareness, expanding access to interventional cardiology and radiology services, and a rising burden of cardiovascular risk factors are driving increased procedural volumes. Furthermore, governments in these regions are investing in the development of tertiary healthcare facilities and rural outreach programs, enhancing access to PAD diagnosis and intervention. Latin America, the Middle East, and parts of Africa are also witnessing gradual uptake as medical tourism, insurance penetration, and healthcare infrastructure improve. Across all regions, increasing physician training and strategic partnerships between medical device manufacturers and hospitals are accelerating the diffusion of iliac stenting technologies.

The Growth in the Iliac Stents Market Is Driven by Several Factors…

The growth in the iliac stents market is driven by several factors related to disease prevalence, technological advancement, and end-use expansion. A primary driver is the rising global incidence of peripheral artery disease, fueled by aging demographics and lifestyle-related risk factors such as smoking, obesity, and sedentary behavior. As PAD becomes more common, the need for effective revascularization options like iliac stents continues to increase. In addition, improvements in diagnostic imaging-such as duplex ultrasonography, CT angiography, and MR angiography-are facilitating early and accurate identification of iliac artery stenosis.

Technological innovation remains a cornerstone of market expansion. The development of new stent platforms-offering enhanced deliverability, reduced restenosis, and longer durability-is attracting physician preference and improving clinical outcomes. End-use applications are also expanding beyond traditional vascular centers to include outpatient clinics and ambulatory surgical centers, enabled by the rise of low-profile, minimally invasive stent systems. Furthermore, favorable regulatory approvals, increasing clinical trial evidence, and growing payer support for endovascular procedures are driving broader adoption.

Lastly, global healthcare trends-such as the shift toward value-based care, increased patient awareness, and integration of artificial intelligence in vascular diagnostics-are reshaping how iliac artery disease is treated. These trends are reinforcing the strategic importance of iliac stents as a frontline therapy for PAD and ensuring sustained demand across regions, healthcare settings, and patient populations.

SCOPE OF STUDY:

The report analyzes the Iliac Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Self-Expandable Stents Type, Balloon-Expandable Stents Type, Covered Stents Type); Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Artery Lesions, Complete Obstructive Artery Lesions); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

Abbott Laboratories
Alvimedica
B. Braun Melsungen AG
Becton, Dickinson and Company (BD)
Biotronik SE & Co. KG
Boston Scientific Corporation
C. R. Bard, Inc.
Cardinal Health, Inc.
Cook Medical LLC
Cordis Corporation
Endologix LLC
Getinge AB
iVascular
Jotec GmbH
LeMaitre Vascular, Inc.
Medtronic plc
MicroPort Scientific Corporation
OptiMed Medizinische Instrumente GmbH
Terumo Corporation
W. L. Gore & Associates, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Iliac Stents - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Incidence of Peripheral Arterial Disease Spurs Demand for Iliac Stents
- Aging Population and Vascular Comorbidities Expand Addressable Market for Endovascular Therapies
- Advancements in Stent Design and Coating Technologies Drive Product Innovation
- Increasing Preference for Minimally Invasive Interventions Propels Iliac Stent Procedure Volume
- Favorable Clinical Outcomes and Long-Term Patency Rates Strengthen Business Case for Iliac Stents
- Expansion of Outpatient Vascular Surgery Centers Enhances Accessibility and Adoption
- Technological Integration in Imaging and Navigation Systems Improves Placement Precision
- Growing Use of Drug-Eluting Stents in Iliac Artery Treatments Accelerates Market Growth
- Rising Awareness and Screening for Peripheral Vascular Disorders Throw Spotlight on Early Intervention
- Clinical Guidelines Endorsing Endovascular Iliac Stenting Drive Physician Adoption
- Product Innovation in Self-Expanding and Balloon-Expandable Stents Expands Therapeutic Options
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Iliac Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Iliac Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Self-Expandable Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Self-Expandable Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Self-Expandable Stents Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Balloon-Expandable Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Balloon-Expandable Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Balloon-Expandable Stents Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Covered Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Covered Stents Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Covered Stents Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Common Iliac Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Common Iliac Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Common Iliac Artery Lesions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Severe Calcified Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Severe Calcified Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for Severe Calcified Artery Lesions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Complete Obstructive Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Complete Obstructive Artery Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 22: World 15-Year Perspective for Complete Obstructive Artery Lesions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 25: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 32: USA Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 33: USA Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 34: USA 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 35: USA Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 36: USA Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 37: USA 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 38: USA Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 39: USA Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 40: USA 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
- TABLE 41: Canada Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: Canada Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 43: Canada 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 44: Canada Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: Canada Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 46: Canada 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 47: Canada Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: Canada Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 49: Canada 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 50: Japan Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: Japan Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 52: Japan 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 53: Japan Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 54: Japan Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 55: Japan 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 56: Japan Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Japan Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 58: Japan 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 59: China Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 60: China Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 61: China 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 62: China Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: China Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 64: China 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 65: China Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: China Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 67: China 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 68: Europe Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 69: Europe Historic Review for Iliac Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 70: Europe 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 71: Europe Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: Europe Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 73: Europe 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 74: Europe Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: Europe Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 76: Europe 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 77: Europe Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 79: Europe 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
FRANCE
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 80: France Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: France Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 82: France 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 83: France Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: France Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 85: France 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 86: France Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: France Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 88: France 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 89: Germany Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: Germany Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 91: Germany 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 92: Germany Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: Germany Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 94: Germany 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 95: Germany Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: Germany Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 97: Germany 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
- TABLE 98: Italy Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Italy Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 100: Italy 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 101: Italy Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Italy Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 103: Italy 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 104: Italy Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: Italy Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 106: Italy 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 107: UK Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: UK Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 109: UK 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 110: UK Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: UK Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 112: UK 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 113: UK Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: UK Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 115: UK 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SPAIN
- TABLE 116: Spain Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: Spain Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 118: Spain 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 119: Spain Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: Spain Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 121: Spain 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 122: Spain Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: Spain Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 124: Spain 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
RUSSIA
- TABLE 125: Russia Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: Russia Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 127: Russia 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 128: Russia Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Russia Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 130: Russia 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 131: Russia Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: Russia Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 133: Russia 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
- TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: Rest of Europe Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 136: Rest of Europe 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: Rest of Europe Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 139: Rest of Europe 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: Rest of Europe Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 142: Rest of Europe 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 144: Asia-Pacific Historic Review for Iliac Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 145: Asia-Pacific 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 147: Asia-Pacific Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 148: Asia-Pacific 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 150: Asia-Pacific Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 151: Asia-Pacific 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 153: Asia-Pacific Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 154: Asia-Pacific 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
AUSTRALIA
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 155: Australia Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 156: Australia Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 157: Australia 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 158: Australia Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 159: Australia Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 160: Australia 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 161: Australia Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 162: Australia Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 163: Australia 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
INDIA
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 164: India Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 165: India Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 166: India 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 167: India Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 168: India Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 169: India 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 170: India Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 171: India Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 172: India 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SOUTH KOREA
- TABLE 173: South Korea Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 174: South Korea Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 175: South Korea 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 176: South Korea Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 177: South Korea Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 178: South Korea 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 179: South Korea Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 180: South Korea Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 181: South Korea 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 183: Rest of Asia-Pacific Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 186: Rest of Asia-Pacific Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 189: Rest of Asia-Pacific Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
LATIN AMERICA
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 191: Latin America Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 192: Latin America Historic Review for Iliac Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 193: Latin America 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 194: Latin America Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 195: Latin America Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 196: Latin America 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 197: Latin America Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 198: Latin America Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 199: Latin America 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 200: Latin America Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 201: Latin America Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 202: Latin America 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ARGENTINA
- TABLE 203: Argentina Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 204: Argentina Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 205: Argentina 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 206: Argentina Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 207: Argentina Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 208: Argentina 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 209: Argentina Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 210: Argentina Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 211: Argentina 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
BRAZIL
- TABLE 212: Brazil Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 213: Brazil Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 214: Brazil 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 215: Brazil Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 216: Brazil Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 217: Brazil 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 218: Brazil Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 219: Brazil Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 220: Brazil 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
MEXICO
- TABLE 221: Mexico Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 222: Mexico Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 223: Mexico 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 224: Mexico Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 225: Mexico Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 226: Mexico 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 227: Mexico Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 228: Mexico Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 229: Mexico 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 231: Rest of Latin America Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 232: Rest of Latin America 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 234: Rest of Latin America Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 235: Rest of Latin America 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 237: Rest of Latin America Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 238: Rest of Latin America 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
MIDDLE EAST
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 239: Middle East Recent Past, Current & Future Analysis for Iliac Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 240: Middle East Historic Review for Iliac Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 241: Middle East 15-Year Perspective for Iliac Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 242: Middle East Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 243: Middle East Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 244: Middle East 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 245: Middle East Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 246: Middle East Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 247: Middle East 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 248: Middle East Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 249: Middle East Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 250: Middle East 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
IRAN
- TABLE 251: Iran Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 252: Iran Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 253: Iran 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 254: Iran Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 255: Iran Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 256: Iran 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 257: Iran Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 258: Iran Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 259: Iran 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ISRAEL
- TABLE 260: Israel Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 261: Israel Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 262: Israel 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 263: Israel Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 264: Israel Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 265: Israel 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 266: Israel Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 267: Israel Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 268: Israel 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SAUDI ARABIA
- TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 270: Saudi Arabia Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 271: Saudi Arabia 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 273: Saudi Arabia Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 274: Saudi Arabia 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 276: Saudi Arabia Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 277: Saudi Arabia 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 278: UAE Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 279: UAE Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 280: UAE 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 281: UAE Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 282: UAE Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 283: UAE 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 284: UAE Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 285: UAE Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 286: UAE 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 288: Rest of Middle East Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 289: Rest of Middle East 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 291: Rest of Middle East Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 292: Rest of Middle East 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 294: Rest of Middle East Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 295: Rest of Middle East 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
AFRICA
- Iliac Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 296: Africa Recent Past, Current & Future Analysis for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 297: Africa Historic Review for Iliac Stents by Type - Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 298: Africa 15-Year Perspective for Iliac Stents by Type - Percentage Breakdown of Value Sales for Self-Expandable Stents Type, Balloon-Expandable Stents Type and Covered Stents Type for the Years 2015, 2025 & 2030
- TABLE 299: Africa Recent Past, Current & Future Analysis for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 300: Africa Historic Review for Iliac Stents by Artery Lesions - Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 301: Africa 15-Year Perspective for Iliac Stents by Artery Lesions - Percentage Breakdown of Value Sales for Common Iliac Artery Lesions, Severe Calcified Artery Lesions and Complete Obstructive Artery Lesions for the Years 2015, 2025 & 2030
- TABLE 302: Africa Recent Past, Current & Future Analysis for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 303: Africa Historic Review for Iliac Stents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 304: Africa 15-Year Perspective for Iliac Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030